France penalizes Novo Nordisk and Eli Lilly for illegal ads
The French National Agency for Medicines announced fines against Novo Nordisk and Eli Lilly for publishing illegal advertisements related to obesity treatments. This action aims to protect the public from the improper use of these treatments.